Administrative Supplement to Aim2Act

Aim2Act 的行政补充

基本信息

批准号：
10665980
负责人：
DAVID A FEDELE
金额：
$ 16.75万
依托单位：
UNIVERSITY OF FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-01 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10665980
关键词：
15 year old Address Adherence Administrative Supplement Adolescent Adolescent Development Affect African American Age Asthma Attention Behavior Behavioral Black American Caregiver support Caregivers Cellular Phone Childhood Childhood Asthma Chronic Disease Communication Data Development Diagnosis Disclosure Disease Ecological momentary assessment Enrollment Environment Ethnic group Family Feedback Frequencies Funding Geographic Locations Goals Guidelines Health Heterogeneity Impaired health Impairment Income Intervention Interview Joints Maintenance Meta-Analysis Methods Modeling Monitor Morbidity - disease rate Neighborhoods Outcome Patients Practice Management Problem Solving Process Protocols documentation Public Health Quality of life Randomized Randomized Controlled Trials Reporting Research Research Personnel Resources Risk Role Sampling Science Self Efficacy Self Management Socioeconomic Status Spirometry Stress Structure Techniques Technology Testing Time Treatment Protocols Unemployment United States National Institutes of Health Variant Work Youth acceptability and feasibility adolescent health attentional control base cost design early adolescence efficacy testing ethnic minority follow-up health disparity improved interest low socioeconomic status mHealth medication compliance neighborhood disadvantage novel parent grant pilot trial poor communities post intervention prevent racial and ethnic recruit skills training social health determinants social influence socioeconomic disadvantage socioeconomics stressor systematic review therapy development treatment effect

项目摘要

PROJECT SUMMARY Asthma is the most prevalent childhood chronic illness, affecting 9.7% of adolescents. National guidelines emphasize the importance of adherence to self-management behaviors for controlling asthma and preventing impaired health and quality of life. Adolescents have suboptimal adherence to asthma self-management behaviors, placing them at risk for morbidity and reduced quality of life. Asthma self-management difficulties emerge in early adolescence as youth begin to transition towards taking more control of their treatment regimen, making it a critical intervention period. The presence of helpful caregiver support is pivotal in determining whether early adolescents ultimately develop and master asthma self-management behaviors. Our interdisciplinary team received NIH funding (PI: Fedele; R21 HD083830) to respond to the critical need for the development of an intervention to facilitate helpful caregiver support in early adolescents (12-15 year-olds) with poorly controlled asthma. AIM2ACT is a dyadic smartphone intervention, informed by the Pediatric Self- Management Model that is specifically tailored to increase helpful caregiver support and adolescent asthma self-efficacy, thereby improving asthma control. AIM2ACT contains three components: 1) ecological momentary assessment to identify personalized strengths and weaknesses in asthma self-management behaviors; 2) collaborative identification and tracking of goals that help early adolescents to become increasingly independent in managing their asthma; and 3) a suite of engaging skills training videos to help dyads understand how to use AIM2ACT and work together to set asthma self-management goals, develop and achieve goals, and engage in problem-solving communication. Results of our pilot trial revealed high feasibility and acceptability of our protocol and preliminary efficacy for AIM2ACT in improving asthma control. The proposed study will test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully- powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver. Families will be randomly assigned to receive AIM2ACT (n=80) or a mHealth attention control condition (n=80) that accounts for staff attention and novelty of a technology-based intervention for 6 months. Dyads in the control condition will not receive personalized asthma management feedback, will not be guided through collaborative identification and tracking of asthma self-management goals, and will not have access to skills training videos. Instead, they will receive static educational information on their smartphones about behavioral management techniques they can use to target improving asthma self- management. The control condition is designed to optimize recruitment and sustain interest while concurrently having a minimal impact on asthma management. Assessments will occur at baseline, post-intervention, and 3-, 6-, and 12-month follow-up time points. Patient-reported (e.g., Asthma Control Test) and objectively monitored (e.g., spirometry, medication adherence) outcomes will be collected.

项目概要哮喘是最常见的儿童慢性疾病，影响 9.7% 的青少年。国家指南强调坚持自我管理行为对于控制哮喘和预防哮喘的重要性健康和生活质量受损。青少年对哮喘自我管理的依从性不佳行为，使他们面临发病风险和生活质量下降。哮喘自我管理困难出现在青春期早期，因为青少年开始过渡到更多地控制自己的治疗治疗方案，使其成为关键的干预时期。有用的护理人员支持的存在至关重要确定早期青少年是否最终发展并掌握哮喘自我管理行为。我们的跨学科团队获得了 NIH 资助（PI：Fedele；R21 HD083830），以满足对制定一项干预措施，以促进对早期青少年（12-15 岁）提供有益的看护者支持哮喘控制不佳。 AIM2ACT 是一种二元智能手机干预措施，由儿科自我干预提供信息专为增加护理人员支持和青少年哮喘而定制的管理模型自我效能感，从而改善哮喘控制。 AIM2ACT包含三个组成部分：1）生态短暂评估以确定哮喘自我管理的个性化优势和劣势行为； 2) 协作识别和跟踪帮助早期青少年成为越来越独立地管理哮喘； 3) 一套引人入胜的技能培训视频来帮助两人了解如何使用 AIM2ACT 并共同努力设定哮喘自我管理目标、发展和实现目标并进行解决问题的沟通。我们的试点试验结果显示出很高的可行性我们的方案的可接受性以及 AIM2ACT 在改善哮喘控制方面的初步功效。这拟议的研究将测试 AIM2ACT 的功效以及在完全- 对 160 名持续性哮喘控制不佳的早期青少年进行的有力随机对照试验，年龄 12-15 岁，有一名看护者。家庭将被随机分配接受 AIM2ACT (n=80) 或 mHealth 注意力控制条件（n = 80），说明员工的注意力和基于技术的新颖性干预6个月。处于对照状态的二人将不会接受个性化哮喘管理反馈，不会通过协作识别和跟踪哮喘自我管理目标来指导，并且将无法访问技能培训视频。相反，他们将收到有关以下方面的静态教育信息：他们的智能手机上有关于行为管理技术的信息，他们可以使用这些技术来改善哮喘的自我治疗管理。控制条件旨在优化招募并维持兴趣，同时对哮喘管理的影响最小。评估将在基线、干预后和 3、6 和 12 个月的随访时间点。患者报告（例如哮喘控制测试）并且客观将收集监测结果（例如肺活量测定、药物依从性）。